Toral Patel

3.4k total citations
68 papers, 2.0k citations indexed

About

Toral Patel is a scholar working on Genetics, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Toral Patel has authored 68 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Genetics, 27 papers in Radiology, Nuclear Medicine and Imaging and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Toral Patel's work include Glioma Diagnosis and Treatment (31 papers), Radiopharmaceutical Chemistry and Applications (11 papers) and Nanoparticle-Based Drug Delivery (8 papers). Toral Patel is often cited by papers focused on Glioma Diagnosis and Treatment (31 papers), Radiopharmaceutical Chemistry and Applications (11 papers) and Nanoparticle-Based Drug Delivery (8 papers). Toral Patel collaborates with scholars based in United States, China and Lebanon. Toral Patel's co-authors include W. Mark Saltzman, Jiangbing Zhou, Joseph M. Piepmeier, Zhaozhong Jiang, Caroline E. Weller, Christopher J. Cheng, Jie Liu, James P. Bertram, Michael C. Fu and Yiyun Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature Materials.

In The Last Decade

Toral Patel

62 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toral Patel United States 20 864 598 470 460 294 68 2.0k
Владимир П. Баклаушев Russia 26 725 0.8× 375 0.6× 256 0.5× 386 0.8× 123 0.4× 157 2.2k
Lingjiao Zhang United States 28 835 1.0× 383 0.6× 721 1.5× 509 1.1× 99 0.3× 58 2.9k
Charles O. Noble United States 30 1.9k 2.2× 1.4k 2.4× 527 1.1× 868 1.9× 457 1.6× 55 3.8k
Brenda Auffinger United States 24 992 1.1× 542 0.9× 698 1.5× 598 1.3× 62 0.2× 38 2.6k
Yu Han United States 28 987 1.1× 403 0.7× 759 1.6× 686 1.5× 72 0.2× 55 3.2k
Mark C. de Gooijer Netherlands 18 781 0.9× 311 0.5× 579 1.2× 378 0.8× 78 0.3× 35 1.7k
Ting Kang China 28 1.1k 1.3× 998 1.7× 125 0.3× 821 1.8× 97 0.3× 53 2.3k
Irina V. Balyasnikova United States 36 1.9k 2.2× 327 0.5× 798 1.7× 915 2.0× 446 1.5× 113 4.2k
Andreas Wunder Germany 20 802 0.9× 259 0.4× 122 0.3× 394 0.9× 372 1.3× 55 2.0k
Mahaveer S. Bhojani United States 23 1.4k 1.6× 483 0.8× 124 0.3× 735 1.6× 264 0.9× 37 2.8k

Countries citing papers authored by Toral Patel

Since Specialization
Citations

This map shows the geographic impact of Toral Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toral Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toral Patel more than expected).

Fields of papers citing papers by Toral Patel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toral Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toral Patel. The network helps show where Toral Patel may publish in the future.

Co-authorship network of co-authors of Toral Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Toral Patel. A scholar is included among the top collaborators of Toral Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toral Patel. Toral Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brenner, Andrew, Toral Patel, Ande Bao, et al.. (2025). Convection enhanced delivery of Rhenium (186Re) Obisbemeda (186RNL) in recurrent glioma: a multicenter, single arm, phase 1 clinical trial. Nature Communications. 16(1). 2079–2079. 7 indexed citations
2.
Yogananda, Chandan Ganesh Bangalore, Benjamin Wagner, Yin Xi, et al.. (2025). Bridging the clinical gap: Confidence informed IDH prediction in brain gliomas using MRI and deep learning. Neuro-Oncology Advances. 7(1). vdaf142–vdaf142. 1 indexed citations
3.
Wagner, Benjamin, Kimmo J. Hatanpaa, Toral Patel, et al.. (2024). Two-Stage Training Framework Using Multicontrast MRI Radiomics for IDH Mutation Status Prediction in Glioma. Radiology Artificial Intelligence. 6(4). e230218–e230218. 6 indexed citations
4.
Enam, Syed Faaiz, Sourav S. Patnaik, Bret M. Evers, et al.. (2024). EXTH-74. COOLING GLIOBLASTOMA WITH A NEURAL IMPLANT. Neuro-Oncology. 26(Supplement_8). viii254–viii254.
5.
Brenner, Andrew, Toral Patel, Michael Youssef, et al.. (2023). TIPS-23 SAFETY AND FEASIBILITY RESULTS FROM A PHASE 1/2 CLINICAL TRIAL OF RHENIUM (186RE) OBISBEMEDA (186RNL) IN RECURRENT GLIOMA: THE RESPECT-GBM TRIAL. Neuro-Oncology Advances. 5(Supplement_3). iii39–iii39. 1 indexed citations
6.
Yogananda, Chandan Ganesh Bangalore, Benjamin Wagner, Kimmo J. Hatanpaa, et al.. (2023). MRI-Based Deep Learning Method for Classification of IDH Mutation Status. Bioengineering. 10(9). 1045–1045. 14 indexed citations
7.
Patel, A., Radhika Kainthla, Farrukh T. Awan, et al.. (2022). Primary central nervous system lymphoma: a real-world comparison of therapy access and outcomes by hospital setting. Neuro-Oncology Practice. 9(3). 183–192. 4 indexed citations
8.
Liu, Jun, Xiaoying Wang, Ann T. Chen, et al.. (2022). ZNF117 regulates glioblastoma stem cell differentiation towards oligodendroglial lineage. Nature Communications. 13(1). 2196–2196. 25 indexed citations
9.
Hsu, Eric J., Elizabeth A. Maher, Michael Youssef, et al.. (2022). Impact of CDKN2A/B, MTAP, and TERT Genetic Alterations on Survival in IDH Wild Type Glioblastomas. Discover Oncology. 13(1). 126–126. 13 indexed citations
10.
Brenner, Andrew, Michael Youssef, Norman LaFrance, et al.. (2022). CTNI-02. PRECLINICAL DATA AND INITIAL CLINICAL EXPERIENCE IN THE PHASE 1/2A DOSE ESCALATION TRIAL OF RHENIUM-186 NANOLIPOSOME (186RNL) IN LEPTOMENINGEAL METASTASES [LM]: THE RESPECT-LM TRIAL. Neuro-Oncology. 24(Supplement_7). vii70–vii70. 1 indexed citations
11.
Yogananda, Chandan Ganesh Bangalore, Bhavya Shah, Sahil Nalawade, et al.. (2021). MRI-Based Deep-Learning Method for Determining Glioma MGMT Promoter Methylation Status. American Journal of Neuroradiology. 42(5). 845–852. 73 indexed citations
12.
Palmisciano, Paolo, Tarek Y. El Ahmadieh, Ali S. Haider, et al.. (2021). Thalamic gliomas in adults: a systematic review of clinical characteristics, treatment strategies, and survival outcomes. Journal of Neuro-Oncology. 155(3). 215–224. 22 indexed citations
13.
Yogananda, Chandan Ganesh Bangalore, Bhavya Shah, Frank Yu, et al.. (2020). A novel fully automated MRI-based deep-learning method for classification of 1p/19q co-deletion status in brain gliomas. Neuro-Oncology Advances. 2(Supplement_4). iv42–iv48. 34 indexed citations
14.
Zhang, Bo, Yan Chen, Xiaolei Shi, et al.. (2020). Regulation of branched-chain amino acid metabolism by hypoxia-inducible factor in glioblastoma. Cellular and Molecular Life Sciences. 78(1). 195–206. 94 indexed citations
15.
Plitt, Aaron, Jack Raisanen, Ankur Patel, et al.. (2019). Intracranial anaplastic hemangiopericytoma presenting with simultaneous extra-cranial metastases: A case report and review of the literature. Surgical Neurology International. 10. 148–148. 6 indexed citations
16.
Guo, Gao, Ke Gong, Vineshkumar Thidil Puliyappadamba, et al.. (2019). Efficacy of EGFR plus TNF inhibition in a preclinical model of temozolomide-resistant glioblastoma. Neuro-Oncology. 21(12). 1529–1539. 24 indexed citations
17.
Panhwar, Muhammad Siyab, Jun Li, Jerry Lipinski, et al.. (2018). Outcomes Among Patients With Heart Failure With Reduced Ejection Fraction Undergoing Transcatheter Aortic Valve Replacement: Minimally Invasive Strategy Versus Conventional Strategy. ˜The œJournal of invasive cardiology. 31(3). 15–20. 3 indexed citations
18.
Patel, Toral. (2014). Nanocarrier-based therapies for CNS tumors. CNS Oncology. 3(2). 115–122. 15 indexed citations
19.
Zhou, Jiangbing, Toral Patel, Rachael W. Sirianni, et al.. (2013). Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma. Proceedings of the National Academy of Sciences. 110(29). 11751–11756. 225 indexed citations
20.
Pereboeva, Larisa, Erik Westin, Toral Patel, et al.. (2013). DNA Damage Responses and Oxidative Stress in Dyskeratosis Congenita. PLoS ONE. 8(10). e76473–e76473. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Владимир П. Баклаушев Breakdown of academic impact, for papers by Lingjiao Zhang Breakdown of academic impact, for papers by Charles O. Noble Breakdown of academic impact, for papers by Brenda Auffinger Breakdown of academic impact, for papers by Yu Han Breakdown of academic impact, for papers by Mark C. de Gooijer Breakdown of academic impact, for papers by Ting Kang Breakdown of academic impact, for papers by Irina V. Balyasnikova Breakdown of academic impact, for papers by Andreas Wunder Breakdown of academic impact, for papers by Mahaveer S. Bhojani
Rankless by CCL
2026